Tag: ROS1

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to ROS1

Chemoimmunotherapy may be preferable for KRAS wild-type NSCLC

Added to Collection on: 2021-04-19 13:07:30

Tags for this article:

Tyrosine kinase receptors
Clusters of differentiation
Lung cancer
Antineoplastic drugs
Non-small-cell lung carcinoma
KRAS
Chemoimmunotherapy
Clinical medicine
ROS1
PD-L1
Anaplastic lymphoma kinase
Branches of biology

Click the tags to see associated articles and topics

View Article Details
Amid a surge of targeted cancer meds, AstraZeneca, Amgen and Roche lead team promoting ...

Added to Collection on: 2021-04-29 13:18:45

Tags for this article:

Biology
Biomarkers
Companies
Branches of biology
Cancer biomarker
Sanofi
AstraZeneca
ROS1
AbbVie

Click the tags to see associated articles and topics

View Article Details
Nuvalent Completes $135 Million Series B Financing to Advance Portfolio of Novel Precisely ...

Added to Collection on: 2021-05-11 09:56:15

Tags for this article:

Tyrosine kinase receptors
Health sciences
Health
Medicine
ROS1
Antineoplastic drugs
Drug discovery
Anaplastic lymphoma kinase
Targeted therapy
Clinical trial
Oncology
Protein kinase inhibitor
Nuvalent Inc.

Click the tags to see associated articles and topics

View Article Details
UPDATE 1-US FDA approves Bristol-Myers' lung cancer drug - Yahoo Finance

Added to Collection on: 2023-11-15 22:18:38

Tags for this article:

Lung cancer
Breakthrough therapy
Orphan drugs
Tyrosine kinase receptors
Antineoplastic drugs
ROS1
Non-small-cell lung cancer
Nivolumab
Protein kinase inhibitor
Bristol-Myers Squibb
Small-cell carcinoma
Tyrosine kinase
Bristol-Myers Squibb's

Click the tags to see associated articles and topics

View Article Details
Innovent's ROS1 TKI closer to winning the Chinese NSCLC market

Added to Collection on: 2024-03-08 19:50:36

Tags for this article:

Tyrosine kinase receptors
Orphan drugs
Tyrosine kinase inhibitors
ROS1
CYP3A4 inhibitors
Lung cancer
Entrectinib
Anaplastic lymphoma kinase
Crizotinib
Non-small-cell lung cancer
Repotrectinib
Amgen
China

Click the tags to see associated articles and topics

View Article Details
Roche wins FDA OK for Alecensa in early lung cancer - Yahoo Finance

Added to Collection on: 2024-04-19 17:50:43

Tags for this article:

Lung cancer
Tyrosine kinase receptors
Fluoroarenes
ROS1
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Brain metastasis
Crizotinib
Alectinib
Cancer
ALK positive lung cancer
Treatment of lung cancer

Click the tags to see associated articles and topics

View Article Details
Machine learning in prediction of epidermal growth factor receptor status in non-small cell ...

Added to Collection on: 2025-05-01 16:53:48

Tags for this article:

Tyrosine kinase receptors
Oncogenes
Carcinogenesis
ROS1
KRAS
Anaplastic lymphoma kinase
Lung cancer
Oncogene
Ras GTPase
Oncovirus
Adenocarcinoma of the lung

Click the tags to see associated articles and topics

View Article Details
Taletrectinib Provides “Prolonged Disease Control” in ROS1+ NSCLC

Added to Collection on: 2025-05-02 19:19:35

Tags for this article:

Tyrosine kinase receptors
ROS1
Tyrosine kinase inhibitors
Lung cancer
CYP3A4 inhibitors
Crizotinib
Non-small-cell lung cancer
Progression-free survival
Entrectinib
Brain metastasis
Clinical endpoint

Click the tags to see associated articles and topics

View Article Details
Lung Adenocarcinoma Competitive Landscape Intensifies With BerGenBio, Innovent, Pfizer ...

Added to Collection on: 2025-09-17 23:10:34

Tags for this article:

Lung cancer
Adenocarcinoma of the lung
Non-small-cell lung cancer
ROS1
Cancer
Carcinoma

Click the tags to see associated articles and topics

View Article Details
Joyo starts its first pivotal trial | ApexOnco - Oncology Pipeline

Added to Collection on: 2025-09-24 19:52:29

Tags for this article:

Tyrosine kinase receptors
Lung cancer
ROS1
Non-small-cell lung cancer
Protein kinase inhibitor
Orphan drugs
Cancer treatments
Monoclonal antibodies
Sugemalimab

Click the tags to see associated articles and topics

View Article Details
Book a Demo